Leadless pacemaker attracts $35m
This article was originally published in Clinica
Executive Summary
A Sunnyvale, California start-up aiming to bring to market the first leadless heart pacing device has raised $35m in a series C financing, led by venture capitalist Delphi Ventures. EBR Systems said it will use the new capital to complete product development and initiate clinical trials of the device for left ventricular stimulation for treating heart failure.